Vivos Therapeutics, Inc. has announced the publication of positive results from a multicenter clinical trial on its Daytime-Nighttime Appliance (DNA) for treating obstructive sleep apnea (OSA) in ...

PORTLAND, OR, UNITED STATES, June 25, 2025 / EINPresswire.com / -- The global sleep apnea oral appliances market is on a sharp growth trajectory, projected to reach $2,337.7 million by 2031, up from ...

Treatment and remedies If sleep apnea is the cause or likely cause of frequently waking up in the middle of the night, a healthcare provider will probably refer the person to a sleep center.

LITTLETON, Colo., June 26, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leader in proprietary, non-invasive treatments for obstructive sleep apnea ...

Learn the risk factors for obstructive sleep apnea, from obesity to fat deposits in the neck to certain medical conditions.